Stay updated on Pembrolizumab in Esophageal Ca Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Esophageal Ca Clinical Trial page.

Latest updates to the Pembrolizumab in Esophageal Ca Clinical Trial page
- Check7 days agoChange DetectedThe page footer revision updated from v3.6.2 to v3.6.3, indicating a newer version of the record.SummaryDifference0.0%

- Check14 days agoChange DetectedA new revision entry 'Revision: v3.6.2' was added to the record history, and the previous entry 'Revision: v3.6.0' was removed, updating the historical record version.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check29 days agoChange DetectedThe study’s recruitment status was updated to no longer look for participants, indicating enrollment has ended. The record now shows a revision to v3.6.0, replacing the previous v3.5.5 in the history.SummaryDifference0.1%

- Check36 days agoChange DetectedThe latest revision entry adds Revision: v3.5.5 and removes Revision: v3.5.4, indicating a small update to the page history.SummaryDifference0.0%

- Check57 days agoChange DetectedThe history section gained new content areas (IPDSharing, Study Design, Study Status, and Study Identification) on 2026-05-13, accompanied by a new revision entry (Revision: v3.5.4). This updates how the study record is structured and tracked over time.SummaryDifference0.2%

- Check78 days agoChange DetectedThe page’s interface revision label was updated from v3.5.2 to v3.5.3, reflecting a site/platform version change without altering the underlying study history details.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Esophageal Ca Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Esophageal Ca Clinical Trial page.